Analysts Set Silicon Laboratories Inc. (NASDAQ:SLAB) Price Target at $136.20

Silicon Laboratories Inc. (NASDAQ:SLABGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $136.20.

SLAB has been the topic of a number of recent analyst reports. StockNews.com lowered shares of Silicon Laboratories from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. Stifel Nicolaus raised their price target on shares of Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Needham & Company LLC reissued a “buy” rating and set a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday. Barclays raised their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a report on Friday, January 17th. Finally, KeyCorp raised their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a report on Wednesday, January 22nd.

Check Out Our Latest Analysis on SLAB

Silicon Laboratories Trading Down 0.6 %

Silicon Laboratories stock opened at $120.98 on Friday. Silicon Laboratories has a 1-year low of $94.00 and a 1-year high of $160.00. The firm has a market capitalization of $3.93 billion, a price-to-earnings ratio of -20.37 and a beta of 1.15. The firm’s fifty day moving average price is $138.66 and its two-hundred day moving average price is $122.76.

Silicon Laboratories (NASDAQ:SLABGet Free Report) last released its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The firm had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. During the same period last year, the firm earned ($1.19) earnings per share. The business’s quarterly revenue was up 91.4% compared to the same quarter last year. On average, research analysts forecast that Silicon Laboratories will post -0.97 EPS for the current year.

Insider Transactions at Silicon Laboratories

In other news, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the completion of the transaction, the director now owns 400,567 shares in the company, valued at $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William G. Bock sold 1,000 shares of Silicon Laboratories stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now owns 31,115 shares of the company’s stock, valued at $4,649,514.45. The trade was a 3.11 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,360 shares of company stock worth $782,610 over the last quarter. Corporate insiders own 1.72% of the company’s stock.

Hedge Funds Weigh In On Silicon Laboratories

Several hedge funds have recently bought and sold shares of the company. FMR LLC grew its stake in Silicon Laboratories by 0.5% during the fourth quarter. FMR LLC now owns 4,867,203 shares of the semiconductor company’s stock valued at $604,604,000 after acquiring an additional 23,833 shares in the last quarter. Vanguard Group Inc. grew its stake in Silicon Laboratories by 1.9% during the fourth quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company’s stock valued at $491,859,000 after acquiring an additional 71,942 shares in the last quarter. Capital Research Global Investors grew its stake in Silicon Laboratories by 23.3% during the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company’s stock valued at $264,827,000 after acquiring an additional 403,010 shares in the last quarter. Wellington Management Group LLP grew its stake in Silicon Laboratories by 28.3% during the third quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock valued at $102,670,000 after acquiring an additional 195,997 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in Silicon Laboratories by 2.1% during the third quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company’s stock valued at $90,282,000 after acquiring an additional 15,728 shares in the last quarter.

Silicon Laboratories Company Profile

(Get Free Report

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

Read More

Analyst Recommendations for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.